Platelet-rich emboli are associated with von Willebrand factor levels and have poorer revascularization outcomes

Andrew Douglas(Ollscoil na Gaillimhe – University of Galway), Karen Doyle(Ollscoil na Gaillimhe – University of Galway), Abhay Pandit(University Hospital Galway), Sarah Power(Beaumont Hospital), Seán Fitzgerald(Discovery Laboratories (United States)), Oana Madalina Mereuta(Mayo Clinic in Arizona), Mikael Jerndal(Sahlgrenska University Hospital), Waleed Brinjikji(WinnMed), István Szikora(Országos Idegsebészeti Tudományos Intézet), Alexandros Rentzos(Sahlgrenska University Hospital), Paul Brennan(National Cancer Institute of Thailand), Lukas Holmegaard(Sahlgrenska University Hospital), Niclas Dehlfors(Sahlgrenska University Hospital), Rosanna Rossi(Ollscoil na Gaillimhe – University of Galway), Turgut Tatlisumak(University of Gothenburg), Alan O’Hare(Beaumont Hospital), Michael Gilvarry(Galway Clinic), Margareta Abrahamsson(Sahlgrenska University Hospital), David F. Kallmes(Mayo Clinic in Arizona), Seán O'Leary(Ollscoil na Gaillimhe – University of Galway), John Thornton(Beaumont Hospital), Ray McCarthy(Galway Clinic), Emma Griffin(Beaumont Hospital)
Journal of NeuroInterventional Surgery
November 4, 2019
Cited by 58


Related Papers